Literature DB >> 12390723

Investigation on current status of in-patient medical service and patient requirements.

Xun-Qiang Guan1, Yu-Hua Zheng, Qi-Qiang Wu, Deng-Li Hu, Yong-Guang Liu, Zhi-Jian Wu, Ping-Yan Chen, Chun-Quan Ou.   

Abstract

OBJECTIVE: To conduct an investigation on current medical service for the in-patients in Zhujiang Hospital and to understand the requirement of the patients for the services.
METHODS: A questionnaire was designed for that purpose to conduct the investigation in 130 in-patients from 19 clinical departments. RESULTS AND
CONCLUSION: With the current medical service provided by the hospital, 87.4% of the patients expressed their satisfaction with the sanitation, 51.3% with the food and 51.3% considered the charges reasonable (to which 6.7% of patients disagreed and 8.3% wished to know the details of the costs from a report every 3 to 5 d). A total of 82.8% of the patients were satisfied with the medical care. As for the requirements and expectations of the medical service, 91.3% of the patients wished to have free rechecks and consultation within certain period after discharge. A proportion of 73.8% of the patients preferred domestically manufactured drugs or those by joint-venture companies, and 11.3% correlated the price of the drugs with their effects. The results also showed the shortage of single ward. As many as 93.2% of the patients wished to choose between alternatives on a basis of thorough knowledge concerning their treatment, but only half of the patients recognized the fulfillment of this right. The results of multiple analysis show that the service after discharge is of great importance in affecting the patients' satisfaction with the general medical service.

Entities:  

Mesh:

Year:  2002        PMID: 12390723

Source DB:  PubMed          Journal:  Di Yi Jun Yi Da Xue Xue Bao        ISSN: 1000-2588


  1 in total

1.  A systematic review of the direct economic burden of type 2 diabetes in china.

Authors:  Huimei Hu; Monika Sawhney; Lizheng Shi; Shengnan Duan; Yunxian Yu; Zhihong Wu; Guixing Qiu; Hengjin Dong
Journal:  Diabetes Ther       Date:  2015-02-05       Impact factor: 2.945

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.